|
CDK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.16989998086592E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.46969999999624E-05 |
| Normal-vs-Stage2 |
1.675750E-02 |
| Normal-vs-Stage3 |
1.170090E-04 |
| Normal-vs-Stage4 |
5.493900E-02 |
| Stage1-vs-Stage2 |
3.750600E-01 |
| Stage1-vs-Stage3 |
3.110200E-02 |
| Stage1-vs-Stage4 |
3.230200E-01 |
| Stage2-vs-Stage3 |
4.920200E-01 |
| Stage2-vs-Stage4 |
8.340200E-01 |
| Stage3-vs-Stage4 |
7.442800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.94090000316916E-08 |
| Normal-vs-AfricanAmerican |
2.3130999999954E-05 |
| Normal-vs-Asian |
1.118580E-01 |
| Caucasian-vs-AfricanAmerican |
4.701200E-01 |
| Caucasian-vs-Asian |
6.799600E-01 |
| AfricanAmerican-vs-Asian |
8.877600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.5420999990381E-08 |
| Normal-vs-Female |
5.87169999954895E-07 |
| Male-vs-Female |
1.080440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.455550E-02 |
| Normal-vs-Extreme_Weight |
9.768600E-04 |
| Normal-vs-Obese |
1.29019999994817E-06 |
| Normal-vs-Extreme_Obese |
4.756600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.493200E-01 |
| Normal_Weight-vs-Obese |
3.912400E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.357400E-01 |
| Extreme_Weight-vs-Obese |
2.315700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.364800E-01 |
| Obese-vs-Extreme_Obese |
9.361900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.201200E-04 |
| Normal-vs-Age(41-60Yrs) |
3.29640004181897E-09 |
| Normal-vs-Age(61-80Yrs) |
7.56500000000937E-05 |
| Normal-vs-Age(81-100Yrs) |
2.181400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.902300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.484700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.764570E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.877900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.966300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.345000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.0095999591897E-09 |
| Normal-VS-Type2 PRCC |
2.637600E-01 |
| Normal-VS-KIRP CIMP |
4.625300E-04 |
| Normal-VS-Unclassified PRCC |
1.242380E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.99659999983371E-07 |
| Type1 PRCC-VS-KIRP CIMP |
4.044600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.390400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.962500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.057170E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.630800E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.068480E-02 |
| Normal-vs-N1 |
5.173600E-04 |
| Normal-vs-N2 |
7.087700E-02 |
| N0-vs-N1 |
1.551890E-02 |
| N0-vs-N2 |
3.372100E-02 |
| N1-vs-N2 |
7.741400E-01 |
|
|
